Status:

RECRUITING

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Lead Sponsor:

Immunovant Sciences GmbH

Conditions:

Graves' Disease

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

This is a study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment. The primar...

Eligibility Criteria

Inclusion

  • Participants with the ability to understand the requirements of the trial, provide written informed consent, and comply with the trial protocol procedures.
  • Male or female participants aged ≥ 18 years.
  • Participants with diagnosis of GD who are hyperthyroid despite ATD treatment.
  • Other, more specific inclusion criteria are defined in the protocol.

Exclusion

  • Have previously been successfully treated with radioactive iodine (RAI) therapy or have undergone total thyroidectomy.
  • Have an autoimmune disease other than GD requiring treatment that, in the Investigator's judgment, puts the participant at undue risk.
  • Have moderate-to-severe active thyroid eye disease (TED) and are expected to require immediate surgical intervention and/or are planning corrective surgery/irradiation or medical therapy for TED during study participation.
  • Additional exclusion criteria are defined in the protocol.

Key Trial Info

Start Date :

December 17 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2028

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT06727604

Start Date

December 17 2024

End Date

June 1 2028

Last Update

March 6 2026

Active Locations (121)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 31 (121 locations)

1

Site Number - 1032

Phoenix, Arizona, United States, 85006

2

Site Number - 1036

Phoenix, Arizona, United States, 85015

3

Site Number - 1061

Huntington Beach, California, United States, 92647

4

Site Number - 1001

Los Angeles, California, United States, 90033